Howmedica, Pfizer Medical Technology Group
Country not established
- Devices
- 1
What Howmedica, Pfizer Medical Technology Group makes
Howmedica, Pfizer Medical Technology Group manufactures the CDH Hip System, a modular hip arthroplasty designed for primary and revision total hip replacements. The system includes acetabular and femoral components intended to restore joint function and mobility in patients with degenerative joint disease or trauma-related damage.
The CDH Hip System is classified as a Class II medical device under FDA regulations and is authorised through the 510(k) clearance pathway. The company operates as a subsidiary of Pfizer and is based in the United States.
Catalogue
Cdh Hip System Ref K922008
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Howmedica, Pfizer Medical Technology Group have in the registry?
The registry currently lists 1 device for Howmedica, Pfizer Medical Technology Group. Devices recorded under merged duplicate company entries are counted once.
Which registries list Howmedica, Pfizer Medical Technology Group's devices?
Among its 1 most recently registered device, Howmedica, Pfizer Medical Technology Group has devices listed in FDA 510(k) (1 device).
What risk classes do Howmedica, Pfizer Medical Technology Group's devices fall under?
Among its 1 most recently registered device, the classes recorded for Howmedica, Pfizer Medical Technology Group's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Howmedica, Pfizer Medical Technology Group in the registry?
The most recently registered devices listed for Howmedica, Pfizer Medical Technology Group include CDH HIP SYSTEM.